VAD Chemotherapy Versus Bortezomib Containing Regimens As Remission Induction For ASCT in Multiple Myeloma: A Single Center Experience

Background: Complete response (CR) and very good partial response (VGPR) are targeted with pre-ASCT induction regimens in patients by diagnosed multiple myeloma (MM), who are candidates for ASCT. In this study, it was aimed to compare the response and survival evaluations of cases who underwent indu...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής

Κύριοι συγγραφείς:	Aysun Senturk Yikilmaz, Sema Akinci, Sule Mine Bakanay, İmdat Dilek
Μορφή:	Artigo
Γλώσσα:	Inglês
Έκδοση:	Tehran University of Medical Sciences 2020-10-01
Σειρά:	International Journal of Hematology-Oncology and Stem Cell Research
Θέματα:	Multiple myeloma, VAD, Autologous stem cell transplantation, Bortezomib
Διαθέσιμο Online:	https://ijhoscr.tums.ac.ir/index.php/ijhoscr/article/view/1216
Ετικέτες:	Προσθήκη ετικέτας Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!